(SY) So-Young International - Ratings and Ratios
Exchange: NASDAQ • Country: China • Currency: USD • Type: Common Stock • ISIN: US83356Q1085
SY: Medical Aesthetics, Beauty, Healthcare, Software, Equipment, Consulting
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty which provides similar interfaces and functions as the mobile app, as well as serves as additional access points to the platform; and medical aesthetic community content through its website soyoung.com. It provides content in various media formats on its online platform generated by users, including professional generated, content from in-house editorial team that shares opinions on specific new medical procedures and trends; user generated content comprising Beauty Diaries that provides details about medical institution, doctor, price, and other information on the treatment; professional user generated, contents from the medical aesthetic influencers; and doctor generated, content from doctors to generate knowledge. In addition, the company offers consumption healthcare services, including dermatology, dentistry and orthodontics, physical examinations, gynecology, and postnatal care; reservation services; and software as a service. Further, it engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment; manufacture and sells light therapy device, surgical laser device and other equipment; internet information and technology advisory; online medical treatment and consultation; management consulting; internet culture; micro finance services, as well as sells cosmetics products. The company was founded in 2013 and is headquartered in Beijing, China., Web URL: https://www.soyoung.com
Additional Sources for SY Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SY Stock Overview
Market Cap in USD | 97m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Interactive Media & Services |
IPO / Inception | 2019-05-02 |
SY Stock Ratings
Growth 5y | -93.6% |
Fundamental | -9.05% |
Dividend | 24.0% |
Rel. Strength Industry | -30.7 |
Analysts | 4.33/5 |
Fair Price Momentum | 0.75 USD |
Fair Price DCF | - |
SY Dividends
Dividend Yield 12m | 6.10% |
Yield on Cost 5y | 0.50% |
Annual Growth 5y | -100.00% |
Payout Consistency | 100.0% |
SY Growth Ratios
Growth Correlation 3m | 70.6% |
Growth Correlation 12m | -65.7% |
Growth Correlation 5y | -80.9% |
CAGR 5y | -39.28% |
CAGR/Max DD 5y | -0.41 |
Sharpe Ratio 12m | 0.16 |
Alpha | -17.12 |
Beta | 0.40 |
Volatility | 67.73% |
Current Volume | 91k |
Average Volume 20d | 93.4k |
What is the price of SY stocks?
As of February 22, 2025, the stock is trading at USD 0.99 with a total of 90,978 shares traded.
Over the past week, the price has changed by +4.20%, over one month by +9.99%, over three months by +10.11% and over the past year by -8.34%.
As of February 22, 2025, the stock is trading at USD 0.99 with a total of 90,978 shares traded.
Over the past week, the price has changed by +4.20%, over one month by +9.99%, over three months by +10.11% and over the past year by -8.34%.
Is So-Young International a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, So-Young International is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SY as of February 2025 is 0.75. This means that SY is currently overvalued and has a potential downside of -24.24%.
Neither. Based on ValueRay Fundamental Analyses, So-Young International is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -9.05 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SY as of February 2025 is 0.75. This means that SY is currently overvalued and has a potential downside of -24.24%.
Is SY a buy, sell or hold?
So-Young International has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy SY.
So-Young International has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy SY.
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for SY stock price target?
According to ValueRays Forecast Model, SY So-Young International will be worth about 0.9 in February 2026. The stock is currently trading at 0.99. This means that the stock has a potential downside of -14.14%.
According to ValueRays Forecast Model, SY So-Young International will be worth about 0.9 in February 2026. The stock is currently trading at 0.99. This means that the stock has a potential downside of -14.14%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 1.2 | 20.2% |
Analysts Target Price | 1.2 | 18.2% |
ValueRay Target Price | 0.9 | -14.1% |